South America Continuous Glucose Monitoring Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

The South American CGM market represents a key segment of the broader Latin American diabetes care devices sector, which is projected to see medium-to-strong growth through 2030. CGM systems provide real-time interstitial glucose readings, replacing or supplementing traditional fingerstick testing, and have become central to modern diabetes management protocols. The market's expansion is underpinned by growing clinical evidence supporting CGM use across both Type 1 and Type 2 diabetes populations, as well as increasing integration of these devices into digital health ecosystems.

• •Market valued at approximately $1.14 billion in 2025 with a 9.5% compound annual growth rate through the forecast period
• •South America represents a key growth region within the global CGM market, driven by rising diabetes incidence and healthcare modernization
• •Expansion is supported by growing adoption of wearable medical devices and digital diabetes care platforms across the region

Rising diabetes incidence across South America is the primary catalyst for CGM market growth, with the International Diabetes Federation documenting increasing prevalence rates in major economies including Brazil, Argentina, and Colombia. Healthcare infrastructure improvements, expanding insurance coverage for diabetes technologies, and growing physician awareness of CGM clinical benefits are accelerating adoption rates.

• •Increasing diabetes incidence across South American populations, particularly in urban centers, is expanding the addressable patient pool for CGM devices
• •Expanding reimbursement coverage and government healthcare initiatives focused on diabetes management are reducing patient cost barriers
• •Integration of pharmacists and multidisciplinary care teams into CGM-enabled diabetes management programs is improving patient outcomes and driving adoption

Brazil dominates the South American CGM market, accounting for the largest share of regional revenue and representing a primary focus for multinational device manufacturers. Mexico, while geographically part of North America, is frequently analyzed alongside Latin American markets and serves as an additional reference point for regional growth dynamics. Smaller markets across the Andean region and Southern Cone are gradually expanding as local regulatory frameworks evolve and import pathways for medical devices improve.

• •Brazil is the largest single-country market in South America for CGM devices, driven by its large diabetes population and relatively advanced private healthcare sector
• •Argentina, Colombia, and Chile represent emerging growth markets with expanding patient access and improving regulatory environments for CGM technologies
• •Market intelligence data identifies South America alongside Mexico as a key emerging growth region for CGM adoption through the 2025-2030 period

What are the recent trends and outlook?

The South American CGM market is expected to benefit from continued digital healthcare investment and the broader trend toward connected, interoperable diabetes management devices through 2030. Technological improvements in sensor longevity, accuracy, and wearability are making CGM systems more attractive to both patients and healthcare providers across the region's varied economic contexts.

• •Investment in digital healthcare infrastructure and wearable medical device connectivity frameworks is expected to expand CGM integration with telemedicine and remote patient monitoring platforms
• •Development of lower-cost CGM alternatives and local manufacturing partnerships may improve affordability and broaden access across middle-income populations in the region
• •Growing emphasis on real-world evidence generation and patient-reported outcomes from South American CGM users is likely to influence both clinical guidelines and reimbursement policies through 2030